PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 47.39 USD 2.11% Market Closed
Market Cap: 3.7B USD

Intrinsic Value

The intrinsic value of one PTCT stock under the Base Case scenario is 35.15 USD. Compared to the current market price of 47.39 USD, PTC Therapeutics Inc is Overvalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PTCT Intrinsic Value
35.15 USD
Overvaluation 26%
Intrinsic Value
Price
Base Case Scenario

Valuation History
PTC Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
PTCT
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for PTCT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

PTC Therapeutics Inc
NASDAQ:PTCT
US
Biotechnology
Market Cap
3.7B USD
IPO
Jun 20, 2013
US
Biotechnology
Market Cap
3.7B USD
IPO
Jun 20, 2013
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PTCT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about PTC Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
PTC Therapeutics Inc

Current Assets 1.4B
Cash & Short-Term Investments 1.1B
Receivables 158.6m
Other Current Assets 67.3m
Non-Current Assets 339.5m
PP&E 117.7m
Intangibles 201.1m
Other Non-Current Assets 20.7m
Efficiency

Free Cash Flow Analysis
PTC Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
PTC Therapeutics Inc

Revenue
806.8m USD
Cost of Revenue
-57.4m USD
Gross Profit
749.4m USD
Operating Expenses
-891.7m USD
Operating Income
-142.3m USD
Other Expenses
-221m USD
Net Income
-363.3m USD
Fundamental Scores

PTCT Profitability Score
Profitability Due Diligence

PTC Therapeutics Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

33/100
Profitability
Score

PTC Therapeutics Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

PTCT Solvency Score
Solvency Due Diligence

PTC Therapeutics Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
36/100
Solvency
Score

PTC Therapeutics Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PTCT Price Targets Summary
PTC Therapeutics Inc

Wall Street analysts forecast PTCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PTCT is 64.55 USD with a low forecast of 42.42 USD and a high forecast of 118.65 USD.

Lowest
Price Target
42.42 USD
10% Downside
Average
Price Target
64.55 USD
36% Upside
Highest
Price Target
118.65 USD
150% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

PTC Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PTCT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PTCT Insider Trading
Buy and sell transactions by insiders

PTCT News

Other Videos
What is the Intrinsic Value of one PTCT stock?

The intrinsic value of one PTCT stock under the Base Case scenario is 35.15 USD.

Is PTCT stock undervalued or overvalued?

Compared to the current market price of 47.39 USD, PTC Therapeutics Inc is Overvalued by 26%.

Back to Top